AvKARE Recalls Fludrocortisone Acetate Tablets Due to Impurity Specifications
AvKARE is recalling 8,866 cartons of Fludrocortisone Acetate Tablets due to failed impurity specifications.
AvKARE has issued a recall for 8,866 cartons of Fludrocortisone Acetate Tablets, USP 0.1mg. The prescription medication was packaged in 50-tablet unit dose AVPAK cartons and distributed nationwide across the United States.
The recall was initiated after the product failed impurities and degradation specifications. Using a drug that has exceeded degradation limits may reduce its effectiveness or cause unintended health effects.
The recall has been designated as a Class II action by the U.S. Food and Drug Administration.
What to do
- Stop taking the recalled medication immediately.
- Consult your healthcare provider or physician to obtain a safe replacement prescription.
- Contact AvKARE or the FDA if you have questions or concerns about the affected product.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | D-0157-2027 |
| Date | 2026-11-11 |
| Company | AvKARE, Pulaski, TN |
| Severity | Class II |
| Quantity | 8866 cartons |
| Where sold | U.S. Nationwide |
| Lot codes / identifiers | Lot # 48353; Exp. 10/31/2026 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.